Stock 9926 AKESO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Akeso, Inc.

Equities

9926

KYG0146B1032

Delayed Hong Kong S.E.
Other stock markets
 08:59:00 14/05/2024 BST 		5-day change 1st Jan Change
49.2 HKD -0.10% Intraday chart for Akeso, Inc. +2.60% +6.25%
04-24 Akeso’s Supplemental New Drug Application for Cervical Cancer Drug Accepted by Chinese Regulator MT
04-24 National Medical Products Administration Accepted the Supplemental New Drug Application by Akeso, Inc. for (Cadonilimab, Pd-1/Ctla-4) as First-Line Treatment for Cervical Cancer CI

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 9926 Stock
  4. News Akeso, Inc.
  5. Transcripts